MyFinsight
Home
Blog
About
XBiotech Inc. (XBIT)
XBiotech Inc. (XBIT)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$4,515K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Foreign exchange loss (gain)
Depreciation
Accounts payable
Others
Negative Cash Flow Breakdown
Net loss
Effect of foreign exchange rate ...
Income tax payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-6,728
-5,505
-26,892
-6,008
Depreciation
302
332
378
427
Deferred tax liability
-
-
5
-
Foreign exchange loss (gain)
-1,412
-1,132
1,170
-1,202
Share-based compensation expense
172
172
162
24
Income tax receivable
14
-
-151
-83
Accrued interest receivable
-25
-58
-90
-30
Prepaid expenses and other current assets
52
246
-17
-254
Accounts payable
246
-678
492
-385
Accrued expenses
212
-4,283
3,896
12
Income tax payable
-90
49
-81
102
Net cash used in operating activities
-4,515
-8,969
-22,952
-4,259
Purchase of property and equipment
0
0
34
110
Permit refund of construction in progress
-4
9
-
-
Net cash provided by (used in) investing activities
-4
9
-34
-110
Payment on convertible loan, third party
-
-
-
0
Payment on from convertible loan, related party-Related Party
0
0
-10,000
-
Payment on from convertible loan, related party-Nonrelated Party
0
0
0
0
Proceeds from issuance of common stock under stock option plan
-
-
-
0
Net cash used in financing activities
0
0
0
0
Effect of foreign exchange rate on cash and cash equivalents
-1,412
-1,132
1,170
2,163
Net change in cash and cash equivalents
-5,931
-10,092
-21,816
-5,571
Cash and cash equivalents, beginning of period
115,459
125,551
147,367
172,677
Cash and cash equivalents, end of period
109,528
115,459
125,551
147,367
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net change in cash
and cash...
-$5,931K
(69.95%↑ Y/Y)
Foreign exchange loss
(gain)
-$1,412K
(-141.96%↓ Y/Y)
Depreciation
$302K
(-65.72%↓ Y/Y)
Accounts payable
$246K
(130.94%↑ Y/Y)
Accrued expenses
$212K
(195.50%↑ Y/Y)
Share-based compensation
expense
$172K
(-94.99%↓ Y/Y)
Accrued interest
receivable
-$25K
(88.64%↑ Y/Y)
Net cash used in
operating activities
-$4,515K
(64.47%↑ Y/Y)
Effect of foreign
exchange rate on cash and...
-$1,412K
(-141.96%↓ Y/Y)
Net cash provided by
(used in) investing...
-$4K
(97.24%↑ Y/Y)
Canceled cashflow
$2,369K
Net loss
-$6,728K
(46.77%↑ Y/Y)
Permit refund of
construction in progress
-$4K
Income tax payable
-$90K
(-257.89%↓ Y/Y)
Prepaid expenses and
other current assets
$52K
(-81.49%↓ Y/Y)
Income tax receivable
$14K
Buy us a coffee